SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-040035
Filing Date
2015-05-07
Accepted
2015-05-07 16:57:41
Documents
2
Period of Report
2015-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2229
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4030
  Complete submission text file 0001209191-15-040035.txt   7788
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address C/O ZIOPHARM ONCOLOGY, INC. 1 FIRST AVE, PARRIS BUILDING #34 BOSTON MA 02129
Business Address
Cooper Laurence James Neil (Reporting) CIK: 0001641506 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33038 | Film No.: 15842664